We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+4.58%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$5.36B
AUM Growth
+$854M
(+19%)
Cap. Flow
+$792M
Cap. Flow
% of AUM
14.77%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
754
New
327
Increased
121
Reduced
79
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$82.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$78.3M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$57.7M |
| 4 |
Teradyne
TER
|
+$56.1M |
| 5 |
AbbVie
ABBV
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$66.1M |
| 2 |
Zimmer Biomet
ZBH
|
+$56.1M |
| 3 |
NVIDIA
NVDA
|
+$55.8M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$54.7M |
| 5 |
eBay
EBAY
|
+$40.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.89% |
| 2 | Technology | 25.02% |
| 3 | Communication Services | 8.75% |
| 4 | Financials | 5.58% |
| 5 | Industrials | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Labcorp
LH
$25.4B
| $18.4M | 0.34% |
77,593
+62,258
| +406% | +$14.2M |
|
|
CNTA
77
DELISTED
Centessa Pharmaceuticals
CNTA
| $18.3M | 0.34% |
+822,518
| New | +$19.3M |
|
|
TRIL
78
DELISTED
Trillium Therapeutics Inc.
TRIL
| $18.1M | 0.34% |
1,866,073
+831,082
| +80% | +$7.82M |
|
79
Acadia Healthcare
ACHC
$2.76B
| $18.1M | 0.34% |
287,863
-12,526
| -4% | -$785K |
|
80
Arrow Electronics
ARW
$11.1B
| $18M | 0.34% |
157,795
+112,894
| +251% | +$13.2M |
|
81
Allogene Therapeutics
ALLO
$649M
| $17.9M | 0.33% |
684,755
+12,111
| +2% | +$345K |
|
82
Nerdy
NRDY
$106M
| $17.8M | 0.33% |
1,793,659
-5,500
| -0.3% | -$55.6K |
|
83
Walt Disney
DIS
$167B
| $17.5M | 0.33% |
+99,316
| New | +$17.9M |
|
84
Diodes
DIOD
$3.78B
| $17M | 0.32% |
213,467
+99,196
| +87% | +$7.62M |
|
85
Fox Class A
FOXA
$24.5B
| $16.8M | 0.31% |
+452,502
| New | +$17M |
|
86
Planet Labs
PL
$7.3B
| $16.8M | 0.31% |
+1,717,205
| New | +$16.9M |
|
87
Agilent Technologies
A
$39.1B
| $16.2M | 0.3% |
109,831
+39,871
| +57% | +$5.44M |
|
88
Acadia Pharmaceuticals
ACAD
$4.43B
| $16.2M | 0.3% |
663,054
+272,463
| +70% | +$6.15M |
|
89
Waters Corp
WAT
$37B
| $16.1M | 0.3% |
46,538
-54,645
| -54% | -$17.3M |
|
90
Viavi Solutions
VIAV
$9.12B
| $15.7M | 0.29% |
891,677
-949,627
| -52% | -$16M |
|
91
Simply Good Foods
SMPL
$901M
| $15.7M | 0.29% |
430,266
+103,446
| +32% | +$3.54M |
|
|
STKL
92
DELISTED
SunOpta
STKL
| $15.7M | 0.29% |
1,278,615
+858,279
| +204% | +$11.2M |
|
93
Arista Networks
ANET
$227B
| $15.6M | 0.29% |
687,456
-641,664
| -48% | -$13.4M |
|
94
Chemed
CHE
$7.07B
| $15.3M | 0.29% |
+32,209
| New | +$15.5M |
|
|
MRTX
95
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $15.2M | 0.28% |
94,276
+63,173
| +203% | +$10.1M |
|
96
Zai Lab
ZLAB
$2.06B
| $15.1M | 0.28% |
85,059
+6,157
| +8% | +$990K |
|
97
Pulmonx
LUNG
$68.8M
| $14.8M | 0.28% |
336,273
+208,181
| +163% | +$9.07M |
|
98
AtaiBeckley Inc
ATAI
$2.66B
| $14.6M | 0.27% |
+791,585
| New | +$14.6M |
|
99
PTC Therapeutics
PTCT
$5.64B
| $14.5M | 0.27% |
343,451
+81,917
| +31% | +$3.51M |
|
100
Cullinan Oncology
CGEM
$1.01B
| $14.5M | 0.27% |
561,206
+18,294
| +3% | +$563K |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Woodline Partners held 754 positions worth $5.36B, up 19% from $4.51B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Woodline Partners deployed $792M of net new capital in Q2 2021, opening 327 new positions and adding to 121 existing holdings. Its largest new stake was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Danaher, an estimated $66.1M trimmed.
- Woodline Partners's largest Q2 2021 buy was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
- Woodline Partners added most to KLA in Q2 2021, an estimated $82.6M increase.
- Woodline Partners's biggest Q2 2021 reduction was Danaher, cutting an estimated $66.1M.
- Woodline Partners fully exited Zimmer Biomet in Q2 2021, selling an estimated $56.1M.
- Woodline Partners's ten largest holdings make up 20% of its $5.36B portfolio in Q2 2021.
- Woodline Partners opened 327 new positions and closed 168 in Q2 2021.
- Woodline Partners's portfolio value rose 19% quarter-over-quarter to $5.36B.
Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.